Drugs / Potato Resistant Starch
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06784336 | Oct 2025 → Oct 2028 expected | disease related to hematopoietic stem cell transplant | University of Michigan Rogel Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Potato Resistant Starch | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06784336 ↗ |
| Known as | RPS | “RPS (Resistant Potato Starch) conditioning phase” NCT06784336 ↗ |
| Modality | Other / unclassified | “a commercially available potato-based resistant starch” NCT06784336 ↗ |